WP
INBX

Woodline Partners’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Woodline Partners’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,318,576
Closed -$88.1M – 678
2023
Q4 		$88.1M Buy
2,318,576
+793,661
+52% +$17M 0.96% 13
2023
Q3 		$28M Hold
1,524,915
– – 0.33% 82
2023
Q2 		$39.6M Buy
1,524,915
+1,210,720
+385% +$28.3M 0.47% 54
2023
Q1 		$5.93M Buy
+314,195
New +$7.31M 0.08% 267
2022
Q4 		– Sell
-103,097
Closed -$1.85M – 988
2022
Q3 		$1.85M Buy
+103,097
New +$1.86M 0.03% 475

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Woodline Partners's INBX Position: Q1 2024 in Review

Woodline Partners sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 2,318,576 shares — an estimated $88.1M sold.

Woodline Partners first reported a position in INBX in Q3 2022 and held it in 5 quarters. The position peaked at $88.1M in Q4 2023. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

  • Woodline Partners reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Woodline Partners sold 2,318,576 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $88.1M.
  • Woodline Partners first reported a position in Inhibrx, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Woodline Partners's Inhibrx, Inc. Common Stock position peaked at $88.1M in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.